LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	84.04	35.14	44.44	18.31
Short-Term Investments	112.08	30.65	-	-
Cash & Short-Term Investments	196.11	65.79	44.44	18.31
Cash Growth	341.29%	48.05%	142.75%	-
Prepaid Expenses	3.12	1.45	2.2	0.02
Total Current Assets	199.35	67.24	46.64	18.32
Property, Plant & Equipment	1.89	0.37	0.28	0.01
Long-Term Deferred Charges	-	2.74	-	-
Other Long-Term Assets	1.4	0.02	0.03	0
Total Assets	202.64	70.38	46.95	18.34
Accounts Payable	4.41	5.71	4.76	0.46
Accrued Expenses	3.53	12.67	4.29	0.79
Current Portion of Leases	0.65	0.14	0.1	-
Current Income Taxes Payable	-	-	0.35	-
Total Current Liabilities	8.58	18.51	9.5	1.25
Long-Term Leases	1.05	0.19	0.15	-
Other Long-Term Liabilities	0.08	0.12	0.07	-
Total Liabilities	9.72	18.83	9.71	1.25
Common Stock	-	5.91	5.91	5.9
Additional Paid-In Capital	315.13	2.52	1.1	0.25
Retained Earnings	-122.15	-95.25	-25.28	-14.47
Comprehensive Income & Other	-0.06	0.01	-	-
Total Common Equity	192.92	-86.81	-18.27	-8.31
Shareholders' Equity	192.92	51.55	37.24	17.08
Total Liabilities & Equity	202.64	70.38	46.95	18.34
Total Debt	1.7	0.33	0.25	-
Net Cash (Debt)	194.41	65.47	44.19	18.31
Net Cash Growth	339.93%	48.14%	141.39%	-
Net Cash Per Share	11.93	6.76	4.67	1.96
Filing Date Shares Outstanding	27.5	25.53	9.63	9.36
Total Common Shares Outstanding	25.85	9.74	9.63	9.36
Working Capital	190.77	48.73	37.14	17.07
Book Value Per Share	7.46	-8.91	-1.90	-0.89
Tangible Book Value	192.92	-86.81	-18.27	-8.31
Tangible Book Value Per Share	7.46	-8.91	-1.90	-0.89
Machinery	-	0.07	0.05	0.02
Leasehold Improvements	-	0.01	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.